Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2025-12-25 @ 9:01 PM
NCT ID:
NCT05323656
Group ID:
EG000
Title:
Setanaxib 1600 mg and Pembrolizumab 200 mg
Description:
Participants will be administered setanaxib at a dose of 1600 mg/day for the up to 24-month double-blind treatment period.
Participants will also be administered Pembrolizumab 200 mg intravenously every 3 weeks.
Setanaxib: Oral tablets, 400 mg per tablet
Pembrolizumab: 200 mg IV infusion
Deaths Number Affected:
6
Deaths Number At Risk:
None
Serious Number Affected:
8
Serious Number At Risk:
27
Other Number Affected:
27
Other Number At Risk:
27
Study:
NCT05323656
Results Section:
NCT05323656
Adverse Events Module:
NCT05323656